A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
To assess if endoscopic ultrasound-guided radiofrequency ablation application in patients
with inoperable pancreatic cancer confers survival benefit when compared to patients
receiving standard medical care.